The burden of rhinitis: Nothing to sniff at

CMAJ. Canadian Medical Association Journal

Volumn 169, Issue 7, 2003, Pages 694-

  Weir, Erica ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACARICIDE; ADRENERGIC RECEPTOR STIMULATING AGENT; ALLERGEN; ANTIHISTAMINIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; HISTAMINE; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E ANTIBODY; IPRATROPIUM BROMIDE; LEUKOTRIENE; NEDOCROMIL; NONSTEROID ANTIINFLAMMATORY AGENT;

BASOPHIL; CLINICAL FEATURE; CLINICAL TRIAL; COGNITION; DERMATOPHAGOIDES PTERONYSSINUS; DESENSITIZATION; DIAGNOSTIC TEST; DRUG INDUSTRY; DUST; FATIGUE; GRASS; HEADACHE; HEALTH CARE COST; HUMAN; IMMUNOTHERAPY; INFLAMMATORY CELL; IRRITABILITY; JOB PERFORMANCE; MAST CELL; NOSE CONGESTION; POLLEN; PREVALENCE; RHINITIS; RHINORRHEA; SHORT SURVEY; SLEEP DISORDER; SNEEZING; WEED;

EID: 0142120644     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (2)

1. Agency for Healthcare Research and Quality. Management of allergic and nonallergic rhinitis [Evidence Report/Technology Assessment no 54]. Washington: The Agency; 2002. Available: www.ahrq.gov/clinic/epcsums/rhinsum.htm (accessed 2003 Aug 25).
2. Agency for Healthcare Research and Quality. Management of allergic rhinitis in the working-age population [Evidence Report/Technology Assessment no 67]. Washington: The Agency; 2003. Available: www .ahrq.gov/clinic/epcsums/rhinworksum.htm (accessed 2003 Aug 25).